Skip to main content
. 2020 Nov 21;11(11):1000. doi: 10.1038/s41419-020-03206-1

Fig. 2. The main differentiated process of ES cells and iPSCs in DN.

Fig. 2

Embryonic stem (ES) cells are pluripotent stem cells derived from the inner cell mass. Then with the treatment of growth factors such as TGF-β1, activin A, BMP-4, HGF, human ES-derived cells can be differentiated into kidney lineage expressing WT1 and the glomerular marker gene rennin in vitro. Induced pluripotent stem cells (iPSCs) are formed by reprogramming terminally differentiated somatic cells with the assistance of specific transcription factors. Human mesangial cells can be induced into pluripotent stem cells through four defined transcription factors, OCT4, SOX2, KLF4, and c-Myc. Another four factors, OCT4, SOX2, NANOG, and LIN28, are sufficient to reprogram human fibroblasts into iPSCs as well. By chemical induction of small molecule inhibitor CHIR99021 of GSK-3β, human iPSCs can differentiate into intermediate mesoderm (IM) followed by FGF-2 and RA and subsequently form tubular structures upon growth factor withdrawal. In serum and feeder-free conditioned systems, hPSCs (referred to as human ES cells and iPSCs) can differentiate into renal progenitor cells (NPCs) which significantly express the specific gene markers SIX2, GDNF, HOXD11, WT1, and CITED1. Next, NPCs have the potential to differentiate into both tubular epithelial cells (TECs) and glomerular podocytes with BMP-7 and FGF-2 in vitro.